Eurofins Scientific revenue and financials
€76.36Change from previous close: +0.29%Absolute change: +€0.22
In the fiscal year ended December 2025, Eurofins Scientific reported revenue of €7.3B (+4.96% year over year). Net income was €474.8M, a net margin of 6.5%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +4.96%
- 2025 vs 2024
- Net income growth
- +16.83%
- 2025 vs 2024
- Net margin
- 6.5%
- 2024: 5.8%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q4 2025 | Q2 2025 |
|---|---|---|
| Total assets | 10,985 | 10,586 |
| Current assets | 2,654 | 2,619 |
| Cash and equivalents | 791 | 753 |
| Inventory | 139 | 146 |
| Net property, plant and equipment | 2,763 | 2,437 |
| Goodwill | 4,657 | 4,596 |
| Other intangible assets | 690 | 711 |
| Long-term investments | 5.3 | 5.8 |
| Current liabilities | 2,430 | 2,085 |
| Accounts payable | 678 | 605 |
| Long-term debt | 3,407 | 3,172 |
| Total debt | 4,432 | 4,114 |
| Total liabilities | 6,409 | 5,914 |
| Total equity (incl. minority) | 4,577 | 4,672 |
| Retained earnings | 3,024 | 2,810 |
| Minority interest | 33.4 | 36.4 |